ArticleMolecular biology reports2026
Virulence arsenal and antibiotic resistance backgrounds in Pseudomonas aeruginosa isolates from hospital wastewater samples from Iraq.
Article in Molecular biology reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe aim of the study was to examine the antibiotic resistance patterns and virulence factors in Pseudomonas aeruginosa isolates in hospital wastewater (HWW).
methodsA total of 155 HWW samples were investigated in Babylon city, Iraq (December 2025 to June 2026). Cellulose ester membrane filters were used to pass the HWW samples. These filters were grown in cetrimide agar. The suspected green colonies of P. aeruginosa species were further determined using a VITEK2 device. Confirmation of the P. aeruginosa isolates was performed through polymerase chain reaction (PCR) of ecfX gene. Disc diffusion testing was used for antibacterial susceptibility. PCR was used to assess the presence of lasA, lasB, toxA, exoS, exoT, exoU, exoY, plcH, plcN, phzI, phzII, apr, algD, and algU virulence genes.
resultsTotally, 119 P. aeruginosa isolates were collected. These isolates showed a high resistance to aztreonam (65.5%) and ceftazidime (58.8%). However, colistin was highly effective (89.9% susceptible). Occurrence of multidrug-resistant (MDR) isolates was 82.4% (n = 98/119). The most prevalent genes were toxA (100.0%), lasB (65.5%), and exoT (65.5%). Significant positive correlations have been found among the following pairs: algU and ciprofloxacin; phzII and piperacillin; phzI and imipenem, ceftazidime, amikacin; plcN and imipenem; plcH and amikacin, piperacillin, piperacillin/tazobactam; exoY and piperacillin; exoT and ceftazidime; and exoS and colistin.
conclusionThe most P. aeruginosa isolates possessed toxA and lasB genes. The results indicated that hospital effluents are critical sources of MDR and virulent P. aeruginosa, and there is an urgent demand to improve the management of wastewater.
Indexed as
Identifiers
42804002What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.